Research highlights
Animal reservoir
One health
HEV Infection in Brazilian Equines
Hepatitis E virus (HEV) infection has been demonstrated in various animal species; those recognized ...
Antiviral agent
Targeting nucleotide synthesis to inhibit HEV
Hepatitis E virus (HEV) infection can cause severe complications and high mortality in pregnant wome...
Antiviral agent
Repurposing of Methotrexate as HEV helicase-inhibitor
In the absence of a globally accessible HEV vaccine, peg-IFNα-2a and ribavirin are the only effecti...
Antiviral agent
FDA-approved RdRp-inhibitors counteract HEV replication
Globally, pegylated interferon-α and ribavirin are the only recommended antiviral agents for treati...
Public health
High prevalence of rat HEV in wastewater treatment plants, Italy
Hepatitis E virus (HEV) infections constitute a significant health problem worldwide, with 4 major g...
Animal reservoir
Public health
HEV in Wild Boars: What Is the Real Zoonotic Risk in Portugal?
Currently, the infection of European wild boars with the Hepatitis E virus (HEV) is seen as an emerg...
Animal reservoir
Food virology
HEV in pigs, pork meat and derived products from the central region of Argentina
Hepatitis E virus (HEV) is an emerging cause of viral hepatitis and several animals such as pigs, wi...
Popular
One health
Rat HEV: a story by Dr. Siddharth Sridhar
Hepatitis E has always fascinated me. Epidemiologically, this virus is a shape-shifter, infecting hu...
Public health
Hepatitis E Outbreaks among refugees and internally displaced persons in sub-Saharan Africa
It is often challenging to obtain the most up-to-date burden of infectious diseases among refugees...
Public health
Introducing a Chinese consortium of hepatitis E
CCSHE, The Chinese Consortium for the Study of Hepatitis E, is an academic association dedicated to ...
Diagnostics
Mapping the changes of serum metabolites in HEV patients
In the past decade, acute liver failure (ALF) caused by hepatitis E virus (HEV) infection has become...
Virology
No evidence for rat HEV infections in humans in Germany
The family Hepeviridae is separated into four species. The best-known is Orthohepevirus A (hepatitis...
Experimental model
Human embryonic and induced pluripotent stem cell-derived HEV culture models
The heterogenous nature of hepatitis E virus (HEV) infections poses clinical challenges. Tropical HE...
Clinical feature
Comparative analysis on clinical characteristics among patients with HAV and HEV
Viral hepatitis is among the most common viral infections in infectious disease departments. They oc...
News
Public health
Hepatitis E in Mexico
The history of hepatitis E virus (HEV) as a causative agent of hepatitis is linked to Mexico. In 198...
JCTH welcomes submissions of hepatitis E research
Journal of Clinical and Translational Hepatology (JCTH, https://www.xiahepublishing.com/journal/jcth...
MSCA Postdoctoral Fellowships 2023
Objective of Postdoctoral Fellowships
The objective of PFs is to support researchers’ careers and...
Update: International HEV Symposium 2023
The Hepatitis E Symposium hosted by the International Vaccine Institute has changed the symposium lo...
Call for Abstracts: International HEV Symposium in Istanbul
The International Vaccine Institute (Seoul, South Korea) is hosting a Hepatitis E Symposium this Apr...
Antiviral agent
PhD awarded to Yunlong Li on hepatitis E research
On 30 August, Yunlong Li defended his PhD thesis on the development of antiviral therapy for treatin...
Public health
Experience of the first HEV vaccination campaign
Hepatitis E outbreaks regularly occur during humanitarian emergencies, often leading to tens of thou...
About us
MISSION & VALUES
Global Hepatitis E Platform
The mission of the Global Hepatitis E Platform is to enhance the global awareness and knowledge about hepatitis E. We connect all stakeholders to join forces for advancing hepatitis E research, education, public health and patient care.
We promote transparency, objectivity and collaboration in pursuit of knowledge and insights, wherever this may lead us.
MANAGEMENT TEAM
EVENTS
2023-04-28
2nd International HEV Symposium
The meeting will be held from April 28 to 29, 2023, in London. The 2-day meeting will feature talks and presentations given on the latest updates on HEV epidemiology, diagnostics, treatment, laboratory research, and disease control. More information: https://www.ivi.int/hev-symposium-2023/
The meeting will be held from April 28 to 29, 2023, in London. The 2-day meeting will feature talks and presentations given on the latest updates on HEV epidemiology, diagnostics, treatment, laboratory research, and disease control. More information: https://www.ivi.int/hev-symposium-2023/
